Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

Many female students at Northern Border University in Saudi Arabia may have Polycystic ovary syndrome (PCOS) and related emotional distress, so those at risk should get further tests and treatment.

Accurate diagnosis of PCOS requires comprehensive androgen measurement.

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

Idiopathic hirsutism may be linked to increased enzyme activity.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Most women with excess hair growth need only a clinical evaluation and minimal tests unless they show signs of virilism.

Leydig cell tumors can cause hormone issues in postmenopausal women even if imaging looks normal.

Spironolactone was effective in reducing hair growth in women with hirsutism.

Follicular targeting could improve hirsutism treatment by focusing directly on hair follicles.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.

The patient with severe hirsutism improved after being diagnosed with non-classic congenital adrenal hyperplasia and treated with corticosteroids.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Cyproterone acetate effectively treats hirsutism and related conditions.

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.